Psychiatry · Houston, TX
NPI
1851385835
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
17115 Red Oak Dr, Ste 109
Houston, TX, 77090
Phone (281) 893-4111
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
590 services
Medicare patients, 2024
145
Average age 66
Drug cost, 2024
$874K
3,607 prescriptions
Company payments, 2025
$43K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence D Ginsberg was code 99213 (office e&m - established), 549 times for 138 patients. In total Lawrence D Ginsberg billed 590 services in 3 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 549 | 138 | $61.40 | $34K |
| 99205 Office E&M - New | Office | 13 | 13 | $168.23 | $2,187 |
By year: 2022 $38K for 585 services; 2023 $39K for 591 services; 2024 $39K for 590 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence D Ginsberg prescribed most often to Medicare patients was Alprazolam, with 472 prescriptions and refills. In total Lawrence D Ginsberg wrote 3,607 Medicare prescriptions that cost $874K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 472 | 567 | 76 | $4,513 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 218 | 305 | 45 | $7,089 |
| Lamotrigine Generic | 212 | 338 | 50 | $2,794 |
| Clonazepam Generic | 212 | 256 | 38 | $2,119 |
| Trazodone Hcl Generic | 150 | 216 | 35 | $1,335 |
| Alprazolam Er Alprazolam | 140 | 214 | 39 | $6,704 |
| Temazepam Generic | 126 | 172 | 25 | $2,140 |
| Vraylar Cariprazine Hcl | 118 | 128 | 19 | $187K |
| Bupropion Xl Bupropion Hcl | 111 | 152 | 25 | $2,136 |
| Lisdexamfetamine Dimesylate Generic | 109 | 113 | 19 | $26K |
| Zolpidem Tartrate Generic | 105 | 150 | 31 | $403 |
| Escitalopram Oxalate Generic | 98 | 174 | 22 | $596 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 93 | 120 | 24 | $4,053 |
| Eszopiclone Generic | 83 | 94 | 20 | $1,399 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 79 | 107 | 15 | $4,259 |
Brand drugs: 461 claims; generic drugs: 3,146 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence D Ginsberg $43K ($43K in general payments such as food, travel and fees) from 24 companies. The largest payer was Alkermes, Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 62 | $19K |
| E.R. Squibb & Sons, L.L.C. BMY | 33 | $17K |
| Tris Pharma Inc | 1 | $5,000 |
| Axsome Therapeutics, Inc. AXSM | 18 | $371 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $258 |
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $207 |
| Abbvie Inc. ABBV | 24 | $198 |
| Lundbeck LLC | 15 | $185 |
| Almatica Pharma LLC | 12 | $174 |
| Vanda Pharmaceuticals Inc. VNDA | 13 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.